These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31637467)

  • 1. A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults.
    Bremmell KE; Briskey D; Meola TR; Mallard A; Prestidge CA; Rao A
    Eur J Nutr; 2020 Sep; 59(6):2729-2737. PubMed ID: 31637467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
    Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO
    Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
    Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
    Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
    Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
    Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF
    J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
    Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
    Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
    Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
    Krokan HE; Bjerve KS; Mørk E
    Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil.
    Schuchardt JP; Schneider I; Meyer H; Neubronner J; von Schacky C; Hahn A
    Lipids Health Dis; 2011 Aug; 10():145. PubMed ID: 21854650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Self-Micro-Emulsifying Delivery System Enhances Enrichment of Eicosapentaenoic Acid and Docosahexaenoic Acid after Single and Repeated Dosing in Healthy Adults in a Randomized Trial.
    West AL; Kindberg GM; Hustvedt SO; Calder PC
    J Nutr; 2018 Nov; 148(11):1704-1715. PubMed ID: 30203029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor
    Kang KM; Jeon SW; De A; Hong TS; Park YJ
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates.
    Maki KC; Dicklin MR
    Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):116-123. PubMed ID: 30550388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial.
    Köhler A; Sarkkinen E; Tapola N; Niskanen T; Bruheim I
    Lipids Health Dis; 2015 Mar; 14():19. PubMed ID: 25884846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial.
    Minton ST; Almada AL; Evans JL; Laidlaw M; Opheim J
    PLoS One; 2023; 18(1):e0265462. PubMed ID: 36706088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro dissolution behaviour and absorption in humans of a novel mixed l-lysine salt formulation of EPA and DHA.
    Manusama K; Balvers M; Diepeveen-de Bruin M; Headley L; Bosi R; Schwarm M; Witkamp R
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102232. PubMed ID: 33360684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Separation of eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester by simulated moving bed chromatography].
    Dong Q; Li M; Yang Y; Bao Z; Yang Q; Zhang Z; Ren Q
    Se Pu; 2018 Sep; 36(9):858-865. PubMed ID: 30251513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal.
    Lawson LD; Hughes BG
    Biochem Biophys Res Commun; 1988 Oct; 156(2):960-3. PubMed ID: 2847723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.